Summary
Thermo Fisher Scientific Inc. (TMO) announced on March 7, 2017, that it has entered into an underwriting agreement to issue and sell €500 million in aggregate principal amount of 1.450% Senior Notes due 2027. The net proceeds from this offering are expected to be approximately €491 million. These proceeds are primarily earmarked for the redemption of the company's outstanding $500 million aggregate principal amount of 1.850% senior notes due 2018. This strategic move aims to refinance existing debt by replacing higher-interest debt with lower-interest debt, thereby potentially improving the company's interest expense and financial flexibility. Any remaining proceeds will be allocated to general corporate purposes.
Key Highlights
- 1Thermo Fisher Scientific is issuing €500 million in new 1.450% Senior Notes due 2027.
- 2The offering is expected to generate approximately €491 million in net proceeds.
- 3The primary use of proceeds is to redeem $500 million of existing 1.850% Senior Notes due 2018.
- 4This debt refinancing aims to reduce the company's interest expenses and optimize its capital structure.
- 5The redemption of the 2018 notes will eliminate this debt maturity in early 2018.
- 6Remaining proceeds will be used for general corporate purposes, including potential acquisitions or debt repayment.
- 7The issuance is being conducted under a registration statement previously filed with the SEC.
Frequently Asked Questions
The main purpose is to refinance existing debt. Thermo Fisher Scientific intends to use the proceeds to redeem its outstanding 1.850% Senior Notes due 2018, replacing higher-interest debt with this new, lower-interest debt.
The company expects to raise approximately €491 million in net proceeds after deducting underwriting discounts and estimated offering expenses from the €500 million issuance of new notes.
The majority of the net proceeds, approximately €491 million, will be used to redeem the outstanding $500 million of 1.850% Senior Notes due 2018. Any remaining funds will be used for general corporate purposes, which may include other debt repayment, capital expenditures, acquisitions, or working capital.
By issuing new notes with a lower interest rate (1.450% vs. 1.850%) and potentially extending the maturity, Thermo Fisher Scientific is likely aiming to reduce its overall interest expense and improve its financial efficiency.